Hypertension Clinical Trial
To determine the distribution of left ventricular hypertrophy and retinal vascular abnormalities in children and adolescents with essential hypertension; to evaluate potential risk factors and the time sequence for the development of these end-organ complications in this population.
BACKGROUND:
Elevated blood pressure has been established as an important risk factor for the development
of cardiovascular disease morbidity and mortality. The major manifestations of end-organ
pathology associated with hypertension include congestive heart failure, ischemic heart
disease, stroke, and peripheral artery disease, including renal failure and retinopathy. As
blood pressure has been studied in children, it has become evident that adult essential
hypertension and its complications may have origins in adolescence and childhood. Clinical
observations have shown that some individuals with elevated blood pressure will develop one
form of morbidity, while others develop a different form, and still others do not develop
any complications. The reasons for this are unknown. Few studies have been done which
attempt to delineate risk factors for the development of the different end-organ pathologies
in hypertensive individuals. Two end-organ problems are particularly amenable to study in
children. Ultrasound examination of the heart allows the non-invasive study of left
ventricular hypertrophy which is an important precursor to the development of congestive
heart failure. Retinal examination by fundal photograph and fluorescein angiography allows
the examination of the effects of elevated blood pressure on the vessels of the eye.
DESIGN NARRATIVE:
The first phase of the study had a cross-sectional design. In this phase, echocardiography
was used to measure left ventricular dimensions, mass, volume and function and fundoscopic
examination and fluorescein angiography were used to determine retinal vascular
abnormalities. Data were collected on the independent variables of age, sex, race, obesity,
level and duration of increased blood pressure, ambulatory variability of blood pressure,
family history of hypertension, treatment with antihypertensive medication, sodium intake,
smoking, alcohol use, fasting blood glucose, hemoglobin, basal plasma renin activity, plasma
catecholamines, cardiovascular reactions to mental stress and to exercise. Multiple
regression analysis was used to determine which of the independent variables were
independently associated with left ventricular mass, creatinine clearance, and retinal
vascular abnormality.
The second phase of the study was a longitudinal investigation of the development of left
ventricular hypertrophy, changes in left ventricular function and retinal vascular disease,
and the temporal relationship of these complications to the risk factors found in the first
phase, using a cohort design.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |